Biocon Biologics is a biosimilars company and subsidiary of Biocon Limited, focused on making life-changing biologic therapies more accessible worldwide. The company develops and commercializes biosimilars across insulins, monoclonal antibodies, and conjugated recombinant proteins, with a commercial footprint spanning over 100 countries. Its mission centers on transforming healthcare by delivering affordable, high-quality biologics to improve patient outcomes and advance health equity globally.